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London EC1M 6BQ, UK and 2Cancer Research UK, Head of Statistical Information, Angel Building, 407 St John Street, London
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Background: Typically, lifetime risk is calculated by the period method using current risks at different ages. Here, we estimate the
probability of being diagnosed with cancer for individuals born in a given year, by estimating future risks as the cohort ages.
Methods: We estimated the lifetime risk of cancer in Britain separately for men and women born in each year from 1930 to 1960.
We projected rates of all cancers (excluding non-melanoma skin cancer) and of all cancer deaths forwards using a flexible age-
period-cohort model and backwards using age-specific extrapolation. The sensitivity of the estimated lifetime risk to the method
of projection was explored.
Results: The lifetime risk of cancer increased from 38.5% for men born in 1930 to 53.5% for men born in 1960. For women it
increased from 36.7 to 47.5%. Results are robust to different models for projections of cancer rates.
Conclusions: The lifetime risk of cancer for people born since 1960 is 450%. Over half of people who are currently adults under
the age of 65 years will be diagnosed with cancer at some point in their lifetime.
What is the probability of developing cancer for someone born
in a given year? The lifetime risk of developing cancer is the
probability that a person will be diagnosed with cancer over the
course of his or her lifetime. The lifetime risk is widely used as a
popular measure of how widespread cancer is in a particular
population (Cancer Research UK, 2012; American Cancer
Society, 2013; National Cancer Institute, 2014). It is commonly
expressed as a percentage (e.g., 25, 33 or 50%) or using odds
(e.g., 1 in 4, 1 in 3 or 1 in 2). The lifetime risk of developing
cancer for individuals born in 1900 is simply the proportion of
that birth cohort that was diagnosed with cancer (assuming
none are still alive and cancer free today). In practice, the cited
lifetime risk is usually an artificial construct obtained by
applying the cancer incidence and the all-cause mortality rates
at different ages in a particular year as if they were to apply to a
cohort as they aged (Feuer et al, 1993; Wun et al, 1998). This
method would only be a true reflection of lifetime risk, if age-
specific cancer rates and all-cause mortality rates were stable
over a long time. Calculating the lifetime risk for an actual
cohort is more complicated because it requires an estimate of
incidence and mortality for the whole lifetime of individuals in
the cohort (Campbell et al, 1994). Here, we combine actual rates
with projected rates in order to estimate the lifetime risk for
men and women born in 1930 and repeat the approach for each
birth cohort from 1931 to 1960.
SUBJECTS AND METHODS
All-causes mortality rates mi(y) (per 100 000 person years) (historic
and projected from 2010 based) for the period ‘y’ 1951–2012 and
projected for 2013–2060 by age ‘i’ (in 5-year bands: 0–4, 5–9, ... 80–
84 and 85þ ) and sex were downloaded from the Office for
National Statistics website (Office of National Statistics, 2012). For
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the calculations here we used rates from 1951 for earlier years
(1930–1950).
National population estimates Ni(y), as well as numbers of all
cancer excluding non-melanoma skin cancer (ICD-10 codes: C00-
C97 excluding C44) diagnoses Ri(y) (for y¼ 1975, ..., 2009) and
numbers of all cancer deaths Di(y) (for y¼ 1971, ... ,2009), by the
5-year age group and sex, were provided by Cancer Research UK.
They in turn received the data from ONS and the relevant national
cancer registries.
The lifetime risk of cancer is estimated from the rates of cancer
(incidence) and all-cause mortality. The basic idea is that at each age
there is a chance of being diagnosed with cancer and a chance of
dying. When the cancer incidence rates include second primaries, it
is necessary to consider the mortality from causes other than cancer
(Sasieni et al, 2011). The lifetime risk is calculated taking into
account the competing risk (for someone who has never had cancer)
of being diagnosed with cancer and death (from something other
than cancer). At any age, an individual can get cancer for the first
time, can die from something other than cancer or can live without
cancer until their next birthday. In Appendix 1, we provide formulae
for the calculation of the lifetime risk from the rate of cancer
incidence, all-cause mortality and cancer mortality. The (more usual)
period estimate of lifetime risk uses rates from a give year. The
cohort estimate uses rates for individuals born in a given year. Thus,
the 1950 cohort will use rates from 1970 for age 20 years and from
2000 for age 50 years.
We also estimate the cumulative risk of cancer (in a cohort) up
to different ages. Informally, the cumulative risk to age 80 years can
be thought of as the probability of being diagnosed with cancer
before the age of 80 years, assuming that there are no competing
causes of death. That is, the risk in someone who does not die of
something else before the age of 80 years. Hence, the cumulative
risk of cancer to age 65 years will be very similar to the lifetime risk
curtailed at the age of 65 years, but the cumulative risk to age of
100 years will be substantially greater than the lifetime risk (as only
a small proportion of people live to 100 years). The advantage of
the cumulative risk of cancer up to age of 85 years (say) is that it
does not depend on all-cause mortality rates. Thus, an increase in
longevity will lead to an increase in the lifetime risk of cancer, but
will have no effect on the cumulative risk.
In order to estimate the rates for years for which there are no
data (i.e., future years and for years before data exist), it is
necessary to model the existing rates and extrapolate. Full details
are provided in Appendix 2. Briefly, cancer incidence ri(y) and
mortality di(y) rates were modelled using age-period-cohort (APC)
models and extrapolated out to the year 2040 using the statistical
method that was published by Mistry et al (2011) (using the Stata
apcspline command (Sasieni, 2012) with default options), in order
to obtain projected rates. Age-specific rates were taken to be
constant beyond 2040. Rates for 1975 were used for all previous
years (1930–1974). Similarly, mortality rates for 1930–1970 were
filled in with 1971 data. Interpolation within each 5-year age group
was done by assuming that rates were constant within the age
group, hence all cancer incidence and mortality rate data were
available for those born from 1930 to 1960 by sex for ages 0–99
years.
Sensitivity analysis. A factorial-design sensitivity analysis was
performed to investigate the effect of various assumptions and
model parameters on the estimated lifetime risk. In particular, we
varied the link function in the generalised linear model, the extent
to which the linear drift is attenuated over time, the number of
knots in the splines used for the age, period and cohort effects in
the model and the method used for estimating rates before 1975.
Exponential and power-5 link functions were used. In addition to
moderate attenuation (75% over 17 years), we considered no
attenuation and rapid attenuation (75% over 6 years). As an
alternative to using 1975 incidence rates for all earlier years, we
used the model fits for 1960–1974 and similarly for 1960–1970 for
cancer mortality rates. In this sensitivity analysis, back projected
rates for 1960 were used for all previous years (1930–1960).
RESULTS
The estimated lifetime risks of developing cancer for men and
women born in different years are presented in Table 1 and
graphically in Figure 1.
The estimated lifetime risk of cancer for both men and women
born in 1930 was 38.5% in men and 36.7% in women (Table 1).
Over 30 years, the risks are projected to increase substantially in
both sexes and the gap between sexes is predicted to increase. For
men born in 1960, the lifetime risk is estimated to be 53.5%
compared with 47.5% for women born in 1960. Table 2 presents
the cumulative risk of cancer up to the 85th birthday (ages 0–84
years). For men born in 1930, the lifetime risk is considerably less
than the cumulative risk 0–84, whereas for those born in 1960 the
lifetime risk is greater: they are very similar for men born in the
late 1940s. In women, the difference in risks for those born in 1930
is only slight, whereas the lifetime risk is much greater than the
cumulative risk 0–84 years for those born in 1960. For both men
and women, the increase in the cumulative risk over 31 years is
considerably less than the increase in lifetime risk.
Figure 1 compares the results of the cohort estimates to the
period estimate using rates from 2010. One can see that the 2010
period estimate of lifetime risk is similar to the cohort estimate for
the 1939 and 1937 birth cohorts for men and women, respectively.
Note that in 2010 men and women born in these years would have
been 71 and 73 years, respectively.
By comparing Tables 1 and 2 one may infer that the main
reason for the substantial increase in lifetime risk is the increasing
life expectancy rather than increasing cancer incidence rates. The
cumulative risk of cancer up to the age of 84 years does not take
Table 1. Estimated lifetime of developing cancer by year of
birth and sex for age group 0–99 years
Year of birth 1930 1935 1940 1945 1950 1955 1960
Male (%) 38.5 42.2 45.4 47.8 49.8 51.5 53.5
Female (%) 36.7 39.7 42.6 44.2 45.3 46.4 47.5
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Figure 1. Estimated cohort lifetime risk for 1930–1960 year of birth
with results from the period for 2010 lifetime risk by sex for UK
population.
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account of competing causes of death. It increased by o4%, in
absolute terms, for those born in 1960 birth cohort compared with
the 1930 birth cohort. By contrast, the lifetime risk in men
increased by 15%.
Figure 2 presents the estimated cumulative risk of cancer for the
1960 birth cohort as it ages (i.e., the cumulative risk from 0 to age
x, for x between 0 and 120 years). The cumulative risk rises rapidly
after the age of 65 years. Indeed, it can be seen that the cumulative
risk up to age 70 years is less than half the lifetime risk. In other
words, over half of the lifetime risk of cancer for the 1960 birth
cohort comes from cancer diagnosed beyond the age of 70 years.
The cumulative risk for men is 12.9, 29.6 and 49.8% for ages 0–64,
0–74 and 0–84 years, respectively. For women, the cumulative risk
is 15.1, 26.4 and 39.9%, respectively.
It is interesting to speculate whether if people lived long enough
virtually everyone would get cancer. The cumulative risk to age 120
years for men is nearly 90% but it is just over 70% for women.
Thus, it would seem that virtually all men would get cancer if they
did not die of other causes first. But in women, whereas the
majority of women would get cancer if they did not die of other
causes first, a substantial minority would not.
Figure 3 shows, for each year of birth, the results of the
sensitivity analysis on the estimated lifetime risk. Each boxplot
presents 54 estimated values of the lifetime risk for a particular sex-
specific birth cohort. The variation in risk over a time is much
greater than the variation in risk due to different methods of
projection. All models estimate the lifetime risk of the 1960 male
birth cohort to be over 50%. The sensitivity to model parameters is
slightly greater for females, but the estimates are virtually all with
±1% of those presented in Figure 1.
DISCUSSION
The lifetime risk of cancer for men born since 1950 is 450%. For
women it is slightly less. The lifetime risk for men born in 1960 is
much greater than for men born in 1930: it increased from 38.5 to
53.5% or by a factor of 1.39 and we would expect this increase to
continue into the future. Much of this increased risk is due to
increasing longevity: the cumulative risk until the age of 84 years
was 46.6% for men born in 1930 and it has increased by a factor of
just 1.07% to 49.8% for men born in 1960. Similar increases are
seen in women, but the impact of increasing longevity is less
dramatic—lifetime risk increases by a factor of 1.30, whereas the
cumulative risk up to the age of 84 years increases by 1.11 (1960
birth cohort compared with that of 1930).
Men born since 1950 have 41 in 2 chance of being diagnosed
with cancer at some point in their lifetime. It is noticeable that the
lifetime risk increased more rapidly for cohorts between 1930 and
1940 than between 1950 and 1960 (Figure 1). To the extent that we
have assumed that cancer rates are constant after age 85 years, we
could have underestimated the lifetime risk in the latter birth
cohorts many of who will live beyond the age of 85 years.
Beyond the effect of increasing longevity, increasing age-specific
rates of cancer have also had an impact on the increasing lifetime
risk of cancer. Whereas smoking-related cancers have become less
common in men, other cancers have become more common.
In women, breast and lung cancers have increased substantially
since the mid 1970’s. The increase in breast cancer is related to
lifestyle changes, such as increasing obesity (Renehan et al, 2008),
women having fewer children, at later ages (Ewertz et al, 1990) and
breast screening detecting more breast cancers at younger ages.
In men, there has been an increase in the incidence of prostate
and bowel cancer. A large proportion of the increase in prostate
cancer diagnoses has been caused by prostate-specific antigen
testing detecting cancers that would not otherwise have been
diagnosed (Bray et al, 2010). The increase in bowel cancer rates is
thought to be related to an increase in red meat consumption and
obesity (Center et al, 2009).
There are some limitations of the available data. We do not have
incidence, mortality or population data to cover the entire lifetime
of the cohorts studied. It should although be noted that someone
born in 1930 would in 2012 either have died already or be 84 years
old, so their lifetime risk of cancer requires little forward
extrapolation. Although we have no incidence data before 1971,
the cumulative risk of cancer to age 40 years (someone born in
1930 would have been 41 years in 1971) is small and variations in
cancer rates in children, teenagers and young adults will have little
Table 2. Estimated cumulative risk of developing cancer by
year of birth and sex for the age group 0–84 years
Year of birth 1930 1935 1940 1945 1950 1955 1960
Male (%) 46.6 46.9 47.7 48.0 48.6 49.2 49.8
Female (%) 36.1 36.8 38.4 39.0 39.4 39.7 39.9
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Figure 2. Estimated cumulative risk for 1960 cohort.
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Figure 3. Estimated cohort lifetime risk for 1930–1960 year of birth
with results from the sensitivity analysis and period for 2010 lifetime
risk by sex for UK population. Note that for males (and females) the
line goes through the exponential models estimates.
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impact on the eventual lifetime risk. By contrast, someone born in
1960 is unlikely to have died and would, in 2012, be 51 years so
most of their lifetime risk is extrapolated.
The sensitivity analysis (Figure 3) shows that although the
method of estimating future (and past) rates affects the final
answer, the variation in lifetime risk resulting from choice of model
parameters is small compared with the variation over 30 years of
birth cohorts. The results are therefore reasonably robust.
The results of this analysis should enhance public health
messages and improve resource planning for both commissioners
and providers of healthcare in the UK. It may also assist clinicians
and patients to weigh the lifetime risk of developing cancer versus
other challenging health risks. Whereas the results of this analysis
are specific to the British population, the methodology can be
applied to other populations.
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APPENDIX 1
Calculation of the lifetime risk of cancer by the cohort method
For the period ‘y’ and age ‘i’: let mi(y) denote the all-causes
mortality rates; ri(y) the incidence of all cancers (excluding non-
melanoma skin cancer; ICD-10 codes C00-C97 excluding C44) and
di(y) the (all) cancer mortality rate.
For ease of notation we drop the argument y when it is constant
(i.e., we write ri for ri(y)).
The lifetime risk, LR can be estimated by using the following
summation over all ages (see Sasieni et al (2011) for further
details): write li¼ riþmi di for the hazard of no longer being
alive and cancer free and define li to be the contribution to the
lifetime risk at age i. Note that li is shorthand for li(y), where y is
the period (and the year of birth is y i).
Let
li ¼ S^0ðiÞri
1 expðliÞ
li
for i ¼ 0; 1; . . . ; 98
and
l99 ¼ S^0ð99Þr99
1
l99
where S^0ðiÞ, the probability of being at risk (i.e., alive and without a
previous diagnosis of cancer) at age (exactly) i is defined as
S^0ðiÞ ¼ exp 
Xi
j¼0
lj
 " #
:
Note that (1 exp{ li})/li is the expected person years at risk
between i and iþ 1for an individual who is alive and cancer free at
age i.
The lifetime risk for period y is
LRPðyÞ ¼
X99
i¼0
liðyÞ:
Similarly we can define the lifetime risk for the cohort born
in y as
LRCðyÞ ¼
X99
i¼0
liðyþiÞ ð1Þ
The cumulative risk up to the fth birthday can be estimated
according to the following formula (Day, 1992):
CRðf Þ ¼ 1 exp 
Xf 1
i¼0
ri
" #
: ð2Þ
Once again the period estimate is obtained by summing the ri(y)
and the cohort estimate by summing the ri(yþ i).
APPENDIX 2
Modelling cancer incidence rates
We use a generalised linear model applied to the numbers of
cancers and population to estimate the rates of cancer by age and
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year of diagnosis (and hence year of birth too). The numbers of
cancers are assumed to be Poisson random variables. The link
function is by default taken to be the canonical link (i.e.,
exponential). We also consider the power-5 link function. The
effects of age, period (i.e., year of diagnosis) and cohort (i.e., year of
birth) are all modelled as natural cubic splines. Knots are placed at
the maximum and minimum value of each variable and internal
knots are placed at evenly spaced percentiles of the data. The
number of internal knots is varied (see Table). The linear trends in
period and cohort are termed drift. In extrapolating the drift into
the future, we assume that the linear trend is dampened by a
certain proportion each year. After k years, we assume that the drift
only increases by this proportion (the damping parameter) raised
to the power k. With damping set to 0.92 (our default) the drift in
the eighth year beyond the last observation is approximately half of
what it is during the period of observation. The non-linear trend in
period is assumed to stop after the last observation. Further details
are provided in Sasieni (2012).
Table: Parameters used in the modelling
Baseline Other values
Link Exponential Power-5
Damping 0.92 0.85, 0.96
Knots: age 6 4, 8
Knots: period 5
Knots: cohort 3 2, 5
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